| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO | Chief Scientific Officer | Ordinary Shares, par value $0.01 per share | 85K | $645K | $7.59 | Jul 28, 2025 | Direct |
| PROTHENA CORP PUBLIC LTD CO | Chief Scientific Officer | Stock Option (Right to Buy) | 108K | Mar 5, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jul 28, 2025 | 1 | $0 | 4 | Jul 30, 2025 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Mar 5, 2025 | 1 | $0 | 4 | Mar 7, 2025 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Feb 27, 2024 | 1 | $0 | 4 | Feb 29, 2024 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Aug 2, 2023 | 4 | -$220K | 4 | Aug 2, 2023 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jul 5, 2023 | 4 | -$224K | 4 | Jul 5, 2023 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jun 7, 2023 | 8 | -$854K | 4 | Jun 7, 2023 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Mar 2, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Feb 23, 2022 | 1 | $0 | 4 | Feb 25, 2022 | Chief Scientific Officer |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jun 22, 2021 | 10 | -$3.27M | 4 | Jun 24, 2021 | Chief Scientific Officer |